SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IMMULOGIC
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
305 5 0 IMUL
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
55 Connaught Labratories (probably the world wide leader in the vaccine field) hasRick Strange-10/14/1996
54 IMUL is certainly under accumulation. It's up 40% (from 7- 1/4 to 10-1/8) Rudy Saucillo-10/14/1996
53 There is one important news item that may well come before the pivotal phase IIPaul Getman-10/7/1996
52 Biotechs can be predictable, but usually there is a run up in the stock price wHarold Engstrom-10/3/1996
51 I like ImmuLogic a lot! Plan on selling my current stock - Taseko Mines- at thMichael Collins-10/2/1996
50 IMUL has published preclinical results of its cocaine vaccine work in the OctobRudy Saucillo-10/1/1996
49 ditto...Harold Engstrom-10/1/1996
48 just keeping it going...Harold Engstrom-9/24/1996
47 Rudy, I can't thank you enough for the "cat" info. I've beeMichael Collins-9/17/1996
46 Greetings, Michael I'm also a follower of IMUL and think they're currRudy Saucillo-9/17/1996
45 Michael, I have no information on the "cat". I work in biotech and rXingbo Wang-9/16/1996
44 Xingbo Wang, Thanks for the info on the Allervax Ragweed, it is very informatiMichael Collins-9/16/1996
43 New Phase III study From BioCentury, Sept. 16, page B10 Punk, Ziegel & KnXingbo Wang-9/16/1996
42 Has ImmuLogic made an announcement on whether they need to do another Phase IIMichael Collins-9/14/1996
41 Paul, I don't have the time right now to send you a proper reply. Your posLyle Abramowitz-5/24/1996
40 Here is an update on developments at IMUL as discussed at their annual meeting Paul Getman-5/23/1996
39 Bhag, Sorry I've been long in replying. Clinical trials are always complLyle Abramowitz-5/17/1996
38 Thanks for the much-needed vote of confidence, Lyle! Actually, my background Paul Getman-5/15/1996
37 Paul, your credibility remains intact! Actually, I have no problems with econoLyle Abramowitz-5/13/1996
36 Actually, I am, of all things, an economist. Do I have any credibility left? Paul Getman-5/11/1996
35 In an optimistic scenario IMUL undertakes another Phase III trial- set back 6 mBhag Karamchandani-5/10/1996
34 Hi Paul, I saw the piece in the WSJ and certainly take that as positive--althoLyle Abramowitz-5/10/1996
33 Hi Lyle, Something to keep in mind regarding IMUL's tests is that they allPaul Getman-5/7/1996
32 Paul, thanks for your informative and insightful reply. I was looking for someLyle Abramowitz-5/6/1996
31 I have a somewhat different view on IMUL's latest trials. The problem herePaul Getman-5/4/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News